Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections

US Patent 11273220 · Granted Mar 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of 2025
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of 2025
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of 2023
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of 2023
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of 2020
Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of 2020
HIV-1 antigens with discrete conformational forms in the V1/V2 domain and method2018
Neutralizing antibodies that bind to the HIV-1 Env V2 critical neutralization do2017
Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadl2015
HIV-1 GP41 neutralization domain and use thereof2013
HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies2004
Fusion glycoproteins1999